New Modified CHA<sub>2</sub>DS<sub>2</sub>-VA Scoring System for Japanese Patients With Non-Valvular Atrial Fibrillation
نویسندگان
چکیده
منابع مشابه
new procedure for treatment of atrial fibrillation in patients with valvular heart disease
patients with valvular heart disease suffer from atrial fibrillation for more than 12 months after valve surgery and have a low probability of remaining in sinus rhythm. we performed an intra-operative procedure similar to surgical maze ііі procedure for conversion of this arrhythmia to sinus rhythm. we did this study to evaluate the efficacy of this procedure to restore the sinus rhythm in pat...
متن کاملNew oral anticoagulants for non-valvular atrial fibrillation--safety issues.
One of the major adverse effects of atrial fibrillation (AF) is stroke which is more disabling and fatal than strokes due to other causes. An individualâs risk of AF related stroke may be reduced by two-thirds with effective anticoagulation with warfarin however it is underused and prescribed to only two thirds of appropriate candidates. Factors contributing to suboptimal warfarin use include...
متن کاملRivaroxaban vs. warfarin in Japanese patients with non-valvular atrial fibrillation in relation to age.
BACKGROUND The J-ROCKET AF study found that rivaroxaban was non-inferior to warfarin with respect to the principal safety outcome in patients with atrial fibrillation (AF). The aim of this subgroup analysis was to assess the safety and efficacy of rivaroxaban and warfarin in relation to patient age. METHODS AND RESULTS A total of 39.0% were elderly (aged ≥75 years). In elderly patients, the p...
متن کاملNewer Anticoagulants for Non-Valvular Atrial Fibrillation
Non-valvular atrial fibrillation is a recognized risk factor for stroke and systemic embolism. It has been clearly established that warfarin reduces the risk of stroke and systemic embolism in persons with atrial fibrillation and additional risk factors for stroke. The use of warfarin, however, requires frequent monitoring, and there is great variability in patient response to warfarin. Warfari...
متن کاملThe Prevalence of Prescription of New Anticoagulant Drugs and Its Determinant Factors in Patients With Ischemic Stroke and Non-valvular Atrial Fibrillation
Background: Patients with ischemic stroke and underlying Atrial Fibrillation (AF) have a high risk of recurrent embolic events. New Oral Anticoagulant (NOAC) is highly effective and reduces the risk of recurrence in AF-associated Ischemic Stroke (AFAIS). Objectives: This study aimed to determine the prescription pattern of NOAC and its determinant factors in patients with non-valvular AFAIS. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation Journal
سال: 2015
ISSN: 1346-9843,1347-4820
DOI: 10.1253/circj.cj-15-0653